Cardiac rupture after thrombolytic therapy: the use of aprotinin to reduce blood loss after surgical repair
- PMID: 1377923
- PMCID: PMC1024899
- DOI: 10.1136/hrt.67.6.504
Cardiac rupture after thrombolytic therapy: the use of aprotinin to reduce blood loss after surgical repair
Abstract
Emergency cardiac surgery after recent thrombolytic therapy is associated with increased blood loss. A patient underwent emergency repair of a ruptured left ventricle after intravenous streptokinase treatment for acute coronary occlusion. High dose aprotinin was given during the operation to reduce the expected blood loss. Surgical repair was successful without bleeding complications. Total postoperative blood loss was 365 ml.
Similar articles
-
Reversal of streptokinase-induced bleeding with aprotinin for emergency cardiac surgery.Anaesthesia. 1992 Mar;47(3):226-8. doi: 10.1111/j.1365-2044.1992.tb02125.x. Anaesthesia. 1992. PMID: 1373586
-
Aprotinin used in emergency coronary operation after streptokinase treatment.Ann Thorac Surg. 1991 Dec;52(6):1320-1. doi: 10.1016/0003-4975(91)90022-i. Ann Thorac Surg. 1991. PMID: 1721803
-
Thrombolysis and postinfarction ventricular septal rupture.J Thorac Cardiovasc Surg. 1992 Dec;104(6):1506-9. J Thorac Cardiovasc Surg. 1992. PMID: 1453713
-
Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.Drugs. 1995 Jun;49(6):954-83. doi: 10.2165/00003495-199549060-00008. Drugs. 1995. PMID: 7543841 Review.
-
[Free-wall rupture during the acute phase of myocardial infarction. Apropos of 2 cases surgically treated with success].Arch Mal Coeur Vaiss. 1991 Apr;84(4):563-7. Arch Mal Coeur Vaiss. 1991. PMID: 2064516 Review. French.
Cited by
-
Perioperative management of drug therapy, clinical considerations.Drugs. 1996 Feb;51(2):238-59. doi: 10.2165/00003495-199651020-00005. Drugs. 1996. PMID: 8808166 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources